September 2025
Answer Questions About 2025-2026 Flu Vaccines
Subscribers will need to be ready to give guidance about this year’s flu vaccines, especially as confusion and misinformation abounds. Our Letter articles discuss which patients should get vaccinated along with which vaccine to recommend. We also give guidance on how to address concerns about thimerosal exposure and explain the difference among various medical organizations’ recommendations. Finally, we point out what’s new with flu vaccines for the coming season. Readers can use our Flu Vaccines for 2025-26 chart to compare products and review our resource, Communicating About Flu Vaccination, for answers to FAQs about immunizing patients who are pregnant, have an egg allergy, and more.
Read More:
Community Pharmacies: Help Patients Send Their Vaping Habits Up in Smoke
Educating patients about the dangers of e-cigarettes is crucial, especially with rising adult vaping rates. Our Letter articles discuss the unique barriers to vaping cessation, such as tracking consumption and the lack of FDA-approved medications. However, we give guidance on an approach for patients that includes considering varenicline or combination nicotine replacement therapy. Readers can compare options with our Smoking Cessation Drug Therapy chart and get answers to other common questions in our E-Cigarettes and Vaping FAQ.
Read More:
Hospitals: Demystify Aztreonam/Avibactam for Abdominal Infections
Your team will start to hear about aztreonam/avibactam (Emblaveo), a new IV antibiotic for complicated intra-abdominal infections (cIAI) that’s active against extended-spectrum beta-lactamases and some carbapenemases. Our Letter articles discuss its limited evidence base, high cost, and the need for formulary restrictions. Additionally, we provide guidance on its role in therapy, dosing, and administration. Readers can check out our aztreonam/avibactam quick skim graphic for a snapshot of dosing, administration, and more.
Read More:
People will have questions about natural food colors, as more popular brands of candy, cereal, and other foods remove artificial colors from their products. Our NatMed article reviews some natural colors recently approved by FDA, such as butterfly pea flower, calcium phosphate, and gardenia blue. We discuss FDA’s process for evaluating color additives, and we advise consumers to check labels to determine which natural or synthetic colors are used.
People will have questions about natural food colors, as more popular brands of candy, cereal, and other foods remove artificial colors from their products. Our NatMed article reviews some natural colors recently approved by FDA, such as butterfly pea flower, calcium phosphate, and gardenia blue. We discuss FDA’s process for evaluating color additives, and we advise consumers to check labels to determine which natural or synthetic colors are used.
Listen to this month’s podcast episode, Meds After Acute Coronary Syndrome, as our expert panel discusses the latest recommendations for managing medications after heart attacks and other cardiac events. You’ll hear our panelists review which antiplatelets to use, the optimal blood pressure meds, and the role of statin and non-statin cholesterol meds.
All Medication Talk episodes offer CE credit to Pharmacist’s Letter and Prescriber Insights subscribers for 2 years after the episode release date. Go to the CE/CME & Training Organizer and search “podcast” to find available courses.
Listen to our latest episode, New Twists to Old Meds: Fresh Formulations of Losartan, Minocycline, and More, as TRC Healthcare editor, Vickie Danaher, PharmD, discusses recently approved drug formulations that bring fresh options—and new challenges—to the pharmacy counter.
Listen to or watch the latest episode, Managing Acne, as hosts Don and Steve tackle one of the most common (and commonly misunderstood) skin conditions: acne. Joined by dermatology expert Sara Klockars, PharmD, BCPS, the team breaks down the myths, meds, and marketing claims that surround acne treatment.
Date: September 17, 20 & 23, 2025
In this month’s live webinar, Pet Meds Unleashed: Keeping Our Furry Patients Safe, you’ll hear our panelists discuss common therapies and unique considerations for our animal companions. And you’ll listen as our panelists share safety guidance, including how to protect pets from potentially harmful human meds.
You can submit any questions you have here and you may hear them answered during the webinar.
Available for APRNs, pharmacists, pharmacy technicians, PAs, physicians, and RNs accreditation and CE/CME:
Date: October 14 & 21, 2025
In this month's live webinar, Oral Oncology Meds: Considerations for Safe Use, you'll hear our panelists discuss critical aspects of managing patients on oral cancer therapies. You'll listen as our experts review tips for optimizing patient care and share best practices for handling these specialized medications.
You can submit any questions you have here and you may hear them answered during the webinar.
Available for APRNs, pharmacists, pharmacy technicians, PAs, physicians, and RNs accreditation and CE/CME:
Upcoming 2025 Live Webinars
Save the date for our “Super Saturday” event on Saturday, September 13th! This event will offer 4 Pharmacy Essential Update sessions back-to-back starting at 7:00am PST/10:00am EST, allowing subscriber to earn 4 hours of live CE credit. Register now in your CE & Training Organizer.
Also, check out our upcoming Pharmacy Essential live CE webinars. Topics include:
September*Pharmacists and pharmacy technicians can earn 1 Hour of CE for each attended webinar.
We'd love to see you in person! Send us a meeting request if you'll be attending any of the following shows:
GLP-1 and GIP/GLP-1 Receptor Agonist Interactive Comparison Chart
Redosing Oral Medications After Vomiting
Our colorful graphic guides readers through pertinent questions to help make decisions about the common scenario of whether patients should receive another medication dose if they’ve vomited.
How to Switch Insulin Products
Managing continuing education and compounding training for your team just got easier. CriticalPoint’s industry-leading training programs are now available on TRC Healthcare’s powerful platform, providing a seamless way to manage CE and compliance for your organization.
Developed by nationally recognized experts and aligned with USP <795>, <797>, and <800>, CriticalPoint is the trusted authority in sterile and nonsterile compounding training.
Our eLearnings, virtual trainings, SOPs, and competency assessments reflect real-world scenarios and regulatory expectations. That’s why over 1,000 facilities—including major health systems and inspector programs—rely on CriticalPoint for credible, practical, and compliant education.
What You’ll Get:
Contact us today to learn how your organization can benefit from CriticalPoint.
Join us on Wednesday, September 17, 2025, at 3pm EST for a free live webinar hosted by CriticalPoint’s Adam West, Course and Curriculum Manager, and Latousha Jackson, Managing Editor. You’ll get an inside look at the industry’s leading training platform for USP <795>, <797>, and <800> compliance.
Whether you manage sterile compounding, hazardous drugs, or pharmacy training across a health system, this session will show you how CriticalPoint supports audit readiness and clinical confidence.
Pharmacy law continues to evolve at a rapid pace—and 2025 is already shaping up to be a year of significant change.
In this webinar, Sue Lunt, Director at Bula, covers the top legislative and regulatory trends impacting pharmacy practice nationwide.
Sue walks through:
*This webinar does not offer CE credits for watching.